Palvella Therapeutics
Rare disease biopharmaceutical company.
Launch date
Employees
Market cap
-
Enterprise valuation
€205m (Public information from Jan 2023)
Radnor Township Pennsylvania (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | - | ||
N/A | $4.4m | Early VC | |
* | $10.0m | Early VC | |
* | $45.0m | Series C | |
* | $9.7m Valuation: $225m | Series D | |
* | N/A | N/A | IPO |
* | $78.9m | Post IPO Equity | |
Total Funding | €62.8m |
Recent News about Palvella Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Palvella Therapeutics
EditACQUISITION by Palvella Therapeutics Jul 2024